Activation of Hypoxia Response in Endothelial Cells Contributes to Ischemic Cardioprotection

REFERENCES

• Kaelin WGJr, Ratcliffe PJ. 2008. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30:393–402.
   PubMed Web of Science ®Google Scholar
• Semenza GL. 2011. Oxygen sensing, homeostasis, and disease. N. Engl. J. Med. 365:537–547.
   PubMed Web of Science ®Google Scholar
• Fraisl P, Aragones J, Carmeliet P. 2009. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat. Rev. Drug Discov. 8:139–152.
   PubMed Web of Science ®Google Scholar
• Minamishima YA, Moslehi J, Bardeesy N, Cullen D, Bronson RT, Kaelin WGJr. 2008. Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood 111:3236–3244.
   PubMed Web of Science ®Google Scholar
• Takeda K, Cowan A, Fong GH. 2007. Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system. Circulation 116:774–781.
   PubMed Web of Science ®Google Scholar
• Moslehi J, Minamishima YA, Shi J, Neuberg D, Charytan DM, Padera RF, Signoretti S, Liao R, Kaelin WGJr. 2010. Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy. Circulation 122:1004–1016.
   PubMed Web of Science ®Google Scholar
• Hölscher M, Silter M, Krull S, von Ahlen M, Hesse A, Schwartz P, Wielockx B, Breier G, Katschinski DM, Zieseniss A. 2011. Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury. J. Biol. Chem. 286:11185–11194.
   PubMed Web of Science ®Google Scholar
• Hyvärinen J, Hassinen IE, Sormunen R, Maki JM, Kivirikko KI, Koivunen P, Myllyharju J. 2010. Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury. J. Biol. Chem. 285:13646–13657.
   PubMed Web of Science ®Google Scholar
• Myllyharju J. 2009. HIF prolyl 4-hydroxylases and their potential as drug targets. Curr. Pharm. Des. 15:3878–3885.
   PubMed Web of Science ®Google Scholar
• Martini JS, Raake P, Vinge LE, DeGeorge BRJr, Chuprun JK, Harris DM, Gao E, Eckhart AD, Pitcher JA, Koch WJ. 2008. Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes. Proc. Natl. Acad. Sci. U. S. A. 105:12457–12462.
   PubMed Web of Science ®Google Scholar
• Gao E, Lei YH, Shang X, Huang ZM, Zuo L, Boucher M, Fan Q, Chuprun JK, Ma XL, Koch WJ. 2010. A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ. Res. 107:1445–1453.
   PubMed Web of Science ®Google Scholar
• Holopainen T, Saharinen P, D'Amico G, Lampinen A, Eklund L, Sormunen R, Anisimov A, Zarkada G, Lohela M, Helotera H, Tammela T, Benjamin LE, Yla-Herttuala S, Leow CC, Koh GY, Alitalo K. 2012. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. J. Natl. Cancer Inst. 104:461–475.
   PubMed Web of Science ®Google Scholar
• Augustin HG, Koh GY, Thurston G, Alitalo K. 2009. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell Biol. 10:165–177.
   PubMed Web of Science ®Google Scholar
• Ignarro LJ, Napoli C, Loscalzo J. 2002. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ. Res. 90:21–28.
   PubMed Web of Science ®Google Scholar
• Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM. 1999. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286:2511–2514.
   PubMed Web of Science ®Google Scholar
• Bao W, Qin P, Needle S, Erickson-Miller CL, Duffy KJ, Ariazi JL, Zhao S, Olzinski AR, Behm DJ, Pipes GC, Jucker BM, Hu E, Lepore JJ, Willette RN. 2010. Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat. J. Cardiovasc. Pharmacol. 56:147–155.
   PubMed Web of Science ®Google Scholar
• Cai Z, Zhong H, Bosch-Marce M, Fox-Talbot K, Wang L, Wei C, Trush MA, Semenza GL. 2008. Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha. Cardiovasc. Res. 77:463–470.
   PubMed Web of Science ®Google Scholar
• Eckle T, Kohler D, Lehmann R, El Kasmi K, Eltzschig HK. 2008. Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 118:166–175.
   PubMed Web of Science ®Google Scholar
• Huang M, Chan DA, Jia F, Xie X, Li Z, Hoyt G, Robbins RC, Chen X, Giaccia AJ, Wu JC. 2008. Short hairpin RNA interference therapy for ischemic heart disease. Circulation 118:S226–S233.
   PubMed Web of Science ®Google Scholar
• Van Herck PL, Paelinck BP, Haine SE, Claeys MJ, Miljoen H, Bosmans JM, Parizel PM, Vrints CJ. 2013. Impaired coronary flow reserve after a recent myocardial infarction: correlation with infarct size and extent of microvascular obstruction. Int. J. Cardiol. 167:351–356.
   PubMedGoogle Scholar
• Bax M, de Winter RJ, Schotborgh CE, Koch KT, Meuwissen M, Voskuil M, Adams R, Mulder KJ, Tijssen JG, Piek JJ. 2004. Short- and long-term recovery of left ventricular function predicted at the time of primary percutaneous coronary intervention in anterior myocardial infarction. J. Am. Coll. Cardiol. 43:534–541.
   PubMedGoogle Scholar
• Suryapranata H, Zijlstra F, MacLeod DC, van den Brand M, de Feyter PJ, Serruys PW. 1994. Predictive value of reactive hyperemic response on reperfusion on recovery of regional myocardial function after coronary angioplasty in acute myocardial infarction. Circulation 89:1109–1117.
   PubMed Web of Science ®Google Scholar
• Jayaweera AR, Wei K, Coggins M, Bin JP, Goodman C, Kaul S. 1999. Role of capillaries in determining CBF reserve: new insights using myocardial contrast echocardiography. Am. J. Physiol. 277:H2363–H2372.
   PubMed Web of Science ®Google Scholar
• Kaul S, Jayaweera AR. 2008. Myocardial capillaries and coronary flow reserve. J. Am. Coll. Cardiol. 52:1399–1401.
   PubMedGoogle Scholar
• Tian H, McKnight SL, Russel DW. 1997. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11:72–82.
   PubMed Web of Science ®Google Scholar
• Jeansson M, Gawlik A, Anderson G, Li C, Kerjaschki D, Henkelman M, Quaggin SE. 2011. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J. Clin. Invest. 121:2278–2289.
   PubMed Web of Science ®Google Scholar
• Kidoya H, Ueno M, Yamada Y, Mochizuki N, Nakata M, Yano T, Fujii R, Takakura N. 2008. Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J. 27:522–534.
   PubMed Web of Science ®Google Scholar
• Takeda Y, Costa S, Delamarre E, Roncal C, Leite de Oliveira R, Squadrito ML, Finisguerra V, Deschoemaeker S, Bruyere F, Wenes M, Hamm A, Serneels J, Magat J, Bhattacharyya T, Anisimov A, Jordan BF, Alitalo K, Maxwell P, Gallez B, Zhuang ZW, Saito Y, Simons M, De Palma M, Mazzone M. 2011. Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 479:122–126.
   PubMed Web of Science ®Google Scholar
• Dezfulian C, Raat N, Shhiva S, Gladwin MT. 2007. Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics. Cardiovasc. Res. 75:327–338.
   PubMed Web of Science ®Google Scholar
• Potente M, Urbich C, Sasaki K, Hofmann WK, Heeschen C, Aicher A, Kollipara R, DePinho RA, Zeiher AM, Dimmeler S. 2005. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J. Clin. Invest. 115:2382–2392.
   PubMed Web of Science ®Google Scholar
• Leucker TM, Bienengraeber M, Muravyeva M, Baotic I, Weihrauch D, Brzezinska AK, Warltier DC, Kersten JR, Pratt PFJr. 2011. Endothelial-cardiomyocyte crosstalk enhances pharmacological cardioprotection. J. Mol. Cell. Cardiol. 51:803–811.
   PubMed Web of Science ®Google Scholar